Scaled Biolabs
About:
Scaled Biolabs accelerates discovery and development of cell therapies, leveraging microfluidics, automation and machine learning.
Website: http://www.scaledbiolabs.com/
Twitter/X: scaledbiolabs
Top Investors: IndieBio, SOSV, California Institute for Regenerative Medicine
Description:
Scaled Biolabs is pioneering a Cell Therapy Discovery Engine, working at the frontier of microfluidics, automation, and machine learning to develop best-in-class cell-based medicines. This engine enables leading biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes, providing an unprecedented window into cell-driven biology. This enables the development of novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson’s disease.
$908000
Less than $1M
San Francisco, California, United States
2016-01-01
mail(AT)scaledbiolabs.com
Brendan Griffen, Drew Titmarsh, Justin Cooper-White
1-10
2017-10-11
Private
© 2025 bioDAO.ai